MCL
BMY icon

MIRAMONTES CAPITAL, LLC’s Bristol-Myers Squibb BMY Stock Holding History

MIRAMONTES CAPITAL, LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Buy
5,715
+115
+2% +$6.6K 0.1% 107
2026
Q1 		$340K Sell
5,600
-2
-0% -$117 0.12% 94
2025
Q4 		$302K Buy
+5,602
New +$269K 0.1% 97

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

MIRAMONTES CAPITAL, LLC's BMY Position: Q2 2026 in Review

MIRAMONTES CAPITAL, LLC increased its Bristol-Myers Squibb (BMY) stake by 2.1% in Q2 2026, buying an estimated $6.6K and bringing the position to 5,715 shares worth $329K. The position accounts for 0.1% of the portfolio, ranked #107.

MIRAMONTES CAPITAL, LLC first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $340K in Q1 2026. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • MIRAMONTES CAPITAL, LLC held 5,715 shares of Bristol-Myers Squibb worth $329K as of Q2 2026.
  • MIRAMONTES CAPITAL, LLC bought 115 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.6K.
  • Bristol-Myers Squibb made up 0.1% of MIRAMONTES CAPITAL, LLC's portfolio in Q2 2026, its #107 holding.
  • MIRAMONTES CAPITAL, LLC first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • MIRAMONTES CAPITAL, LLC's Bristol-Myers Squibb position peaked at $340K in Q1 2026.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on MIRAMONTES CAPITAL, LLC's 13F filing for Q2 2026, filed 9 Sep 2026.